A note on thyroid hormones: Carnitine has traditionally been used by individuals with hyperthyroidism to help with symptoms resulting from hyperthyroid-induced carnitine depletion (such as muscle wasting), so scientists initially believed that carnitine acted like an antagonist or a thyroid hormone receptor blocker, and cautioned against using carnitine in hypothyroidism
GHRP-6 in Cytoprotection and Tissue Repair GHRP-6's research literature extends significantly beyond GH release into tissue protection and repair : Stroke therapy: A Phase I/II clinical trial examined GHRP-6 combined with recombinant EGF for acute ischemic stroke one of the few GHS compounds to reach clinical trials for a non-endocrine indication (Berlanga-Acosta et al., 2024) Lung injury: GHRP-6 ameliorates acute lung injury and prevents its progression to interstitial fibrosis in preclinical models (GHRP-6 in lung injury, 2025) Organ failure prevention: GHRP-6 has been investigated for multiple organ failure prevention in critical illness (Berlanga-Acosta et al., 2006) Cardiac protection: The peptide protects against doxorubicin-induced cardiotoxicity through prosurvival pathway activation (GHRP-6 cardioprotection, 2024) These cytoprotective effects appear to involve GHSR-1a-mediated anti-inflammatory, anti-apoptotic, and antioxidant signaling potentially independent of GH release itself
To confirm the involvement of ASBT-facilitated transport of oligomeric DOCA-G1As across the epithelial membrane in the GI tract, the Caco-2 cell permeability of each oligomeric DOCA-G1A was analyzed in the presence or absence of specific inhibitors for ASBT (Act D) and OST / (CFZ)
The amount of weight loss varies between patients
